Medicine Overview
Adult Dose
| Clinical Information | Administration Information |
|---|---|
|
Indication: Candidiasis Treatment (esophageal) |
Dose: Intravenous infusion – 150 mg/day Duration: 10 to 30 days (mean 15 days) |
|
Indication: Prophylaxis in hematopoietic stem cell transfer (HSCT) patients |
Dose: Intravenous infusion – 50 mg/day Duration: 6 to 51 days (mean 19 days) |
Child Dose
| Clinical Information | Administration Information |
|---|---|
|
Indication: Candida Infections Age: less than 4 months |
Dose: Not established Note: Safety and efficacy not established |
|
Indication: Treatment of Candidemia, acute disseminated candidiasis, Candida peritonitis and abscesses Age: greater than 4 months |
Dose: Intravenous – 2 mg/kg Frequency: once daily Note: not to exceed 100 mg/day |
Administration
- For IV infusion only
- Must be diluted before use
Side Effect
- Abd pain
- Anemia
- Headache
- Diarrhea
- Increased LFTs
- Leukopenia
- Nausea
- Neutropenia
- Phlebitis
- Pruritus
- Pyrexia
- Rash
- Rigors
- Thrombocytopenia
- Vomiting
- Facial swelling
- Vasodilation
- Delirium
- Dizziness
- Somnolence
Drug Interaction
Drug Interaction
| Drug Name | Risk Factors |
|---|---|
|
Amphotericin B desoxycholate, sirolimus, nifedipine, itraconazole
|
May increase exposure
|
Disease Interaction
Disease Interaction
| Disease Name | Risk Factors |
|---|---|
|
No specific contraindications listed
|
Monitor for general reactions
|
Pregnancy
Pregnancy
Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage
Details coming soon
Data Sources
Clinical & regulatory information on this page is compiled from the following government sources:
DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.